• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 34

Substance: Aspartic proteinase derived from Aspergillus oryzae carrying a gene encoding aspartic proteinase from Rhizomucor miehei
Intended Use: Use in meat as a tenderizing agent at minimum levels necessary to accomplish the intended technical effect in accordance with current good manufacturing practices
Basis: Scientific procedures
Notifier: Novo Nordisk
77 Perry Chapel Church Rd., Box 576; Franklinton, NC 27525
Date of filing: Nov 17, 1999
GRAS Notice (releasable information): 34
Date of closure / FDA's Letter: Apr 19, 2000
FDA has no questions